1Burns GF, Triglia T, Werkmeister JA, et al. TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors [J]. J Exp Med, 1985, 161(5): 1063-1078.
2Scott JL, Dunn SM, Jin B, et al. Characterization of a novel membrane glycoprotein involved in platelet activation [J]. J Biol Chem,1989, 264(23): 13475-13482.
3Jia W, Liu XS, Zhu Y, et al. Preparation and characterization of mabs against different epitopes of CD226 (PTA1) [J]. Hybridoma,2000, 19(6): 489 -494.
4Bottino C, Castriconi R, Pende D, et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule[J]. J Exp Med, 2003,198(4): 557 -567.
5Reymond N, Imbert AM, Devilard E, et al. DNAM-1 and PVR regulate monocyte migration through endothelial junctions[J]. J Exp Med,2004, 199(10): 1331 - 1341.
6Castriconi R, Dondero A, Corrias MV, et al. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction [J]. Cancer Res, 2004, 64(24): 9180 -9184.
7Tomasec P, Wang EC, Davison A J, et al. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141[J]. Nat Immunol, 2005, 6(2): 181 -188.
8Ma D, Sun Y, Lin D, et al. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization [J]. Eur J Haemato, 2005, 74 (3):228 - 240.
9Shibuya K, Lanier LL, Phillips JH, et al. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule[J]. Immunity, 1999, 11(5):615-623.
